NASDAQ · TENK
TenX Keane Acquisition Ordinary Share
$40.50+$3.00 (+8.0%)
TenX Keane Acquisition Ordinary Share’s quoted price sits in the upper half of its reported 52-week range, 17.35% below the high.
Loading market information…
NASDAQ · DALS · USD
Stock price, earnings
Quote as of Jul 28, 2023, 07:51 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
DA32 Life Science Tech Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 8.2% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow DA32 Life Science Tech Acquisition Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Currently, DA32 Life Science Tech Acquisition Corp. does not engage in substantial operational activities. Its core objective is to finalize a business combination, which may involve a merger, an exchange of capital stock, an acquisition of assets or stock, or a corporate reorganization with other companies. The firm intends to pinpoint promising candidates for these combinations within the biotechnology and life science infrastructure sectors. Established in 2021, the company is based in New York, New York.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:53 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
KEEP COMPARING
$40.50+$3.00 (+8.0%)
TenX Keane Acquisition Ordinary Share’s quoted price sits in the upper half of its reported 52-week range, 17.35% below the high.
$10.98+$0.02 (+0.18%)
TortoiseEcofin Acquisition Corp. III’s quoted price sits in the upper half of its reported 52-week range, 3.94% below the high.
$10.51+$0.01 (+0.1%)
SILVERspac Inc.’s quoted price sits in the upper half of its reported 52-week range, 4.19% below the high.
$13.05+$1.66 (+14.57%)
Ignyte Acquisition Corp.’s quoted price sits in the upper half of its reported 52-week range, 13.0% below the high.
$5.08-$1.03 (-16.86%)
Ventoux CCM Acquisition Corp.: Financial Services · Shell Companies.
$10.23-$0.01 (-0.05%)
Corazon Capital V838 Monoceros Corp’s quoted price sits in the upper half of its reported 52-week range, 0.15% below the high.
$10.24-$0.01 (-0.1%)
Panacea Acquisition Corp. II’s quoted price sits in the lower half of its reported 52-week range, 6.23% below the high.
$10.95-$0.01 (-0.09%)
CC Neuberger Principal Holdings III’s quoted price sits in the upper half of its reported 52-week range, 5.6% below the high.
